149 related articles for article (PubMed ID: 31413179)
1. Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma.
Xie X; Chen Y; Hu Y; He Y; Zhang H; Li Y
Mol Cancer Ther; 2019 Dec; 18(12):2258-2269. PubMed ID: 31413179
[TBL] [Abstract][Full Text] [Related]
2. Generation of cytotoxic T lymphocytes specific for native or modified peptides derived from the epidermal growth factor receptor pathway substrate 8 antigen.
Li Y; Zhou W; Du J; Jiang C; Xie X; Xue T; He Y
Cancer Immunol Immunother; 2015 Feb; 64(2):259-69. PubMed ID: 25376540
[TBL] [Abstract][Full Text] [Related]
3. A dual-function epidermal growth factor receptor pathway substrate 8 (Eps8)-derived peptide exhibits a potent cytotoxic T lymphocyte-activating effect and a specific inhibitory activity.
Xie X; Zhou W; Hu Y; Chen Y; Zhang H; Li Y
Cell Death Dis; 2018 Mar; 9(3):379. PubMed ID: 29515106
[TBL] [Abstract][Full Text] [Related]
4. Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
Bae J; Smith R; Daley J; Mimura N; Tai YT; Anderson KC; Munshi NC
Clin Cancer Res; 2012 Sep; 18(17):4850-60. PubMed ID: 22753586
[TBL] [Abstract][Full Text] [Related]
5. Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.
Li R; Qian J; Zhang W; Fu W; Du J; Jiang H; Zhang H; Zhang C; Xi H; Yi Q; Hou J
Br J Haematol; 2014 Sep; 166(5):690-701. PubMed ID: 24824351
[TBL] [Abstract][Full Text] [Related]
6. Identification of human leukemia antigen A*0201-restricted epitopes derived from epidermal growth factor pathway substrate number 8.
Tang B; Zhou W; Du J; He Y; Li Y
Mol Med Rep; 2015 Aug; 12(2):1741-52. PubMed ID: 25936538
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of multiple myeloma by B cell maturation antigen (BCMA)-specific central memory CD8
Bae J; Samur M; Richardson P; Munshi NC; Anderson KC
Leukemia; 2019 Sep; 33(9):2208-2226. PubMed ID: 30872779
[TBL] [Abstract][Full Text] [Related]
8. [Prediction and Identification of HLA-A*0201 Restricted CTL Epitopes from Eps8].
Du JW; Wang YX; Zhou WJ; Jiang CJ; Xie XL; Zhang HH; He YJ; Li YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):865-72. PubMed ID: 27342524
[TBL] [Abstract][Full Text] [Related]
9. A novel multi-epitope vaccine from MMSA-1 and DKK1 for multiple myeloma immunotherapy.
Lu C; Meng S; Jin Y; Zhang W; Li Z; Wang F; Wang-Johanning F; Wei Y; Liu H; Tu H; Su D; He A; Cao X; Zhou F
Br J Haematol; 2017 Aug; 178(3):413-426. PubMed ID: 28508448
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma.
Bae J; Carrasco R; Lee AH; Prabhala R; Tai YT; Anderson KC; Munshi NC
Leukemia; 2011 Oct; 25(10):1610-9. PubMed ID: 21660045
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD19 and CD20 peptides for induction of antigen-specific CTLs against B-cell malignancies.
Bae J; Martinson JA; Klingemann HG
Clin Cancer Res; 2005 Feb; 11(4):1629-38. PubMed ID: 15746068
[TBL] [Abstract][Full Text] [Related]
12. A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients.
Bae J; Prabhala R; Voskertchian A; Brown A; Maguire C; Richardson P; Dranoff G; Anderson KC; Munshi NC
Leukemia; 2015 Jan; 29(1):218-29. PubMed ID: 24935722
[TBL] [Abstract][Full Text] [Related]
13. Identification of HLA‑A*1101‑restricted cytotoxic T lymphocyte epitopes derived from epidermal growth factor pathway substrate number 8.
Lu H; Tang B; He Y; Zhou W; Qiu J; Li Y
Mol Med Rep; 2016 Dec; 14(6):4999-5006. PubMed ID: 27840923
[TBL] [Abstract][Full Text] [Related]
14. Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma.
Alatrash G; Perakis AA; Kerros C; Peters HL; Sukhumalchandra P; Zhang M; Jakher H; Zope M; Patenia R; Sergeeva A; Yi S; Young KH; Philips AV; Cernosek AM; Garber HR; Qiao N; Weng J; St John LS; Lu S; Clise-Dwyer K; Mittendorf EA; Ma Q; Molldrem JJ
Clin Cancer Res; 2018 Jul; 24(14):3386-3396. PubMed ID: 29661776
[No Abstract] [Full Text] [Related]
15. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
16. CD19 chimeric antigen receptor-redirected T cells combined with epidermal growth factor receptor pathway substrate 8 peptide-derived dendritic cell vaccine in leukemia.
Wu M; Zhang L; Zhang H; Ning J; Tu S; He Y; Li Y
Cytotherapy; 2019 Jun; 21(6):659-670. PubMed ID: 31031152
[TBL] [Abstract][Full Text] [Related]
17. Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma.
Qian J; Zheng Y; Zheng C; Wang L; Qin H; Hong S; Li H; Lu Y; He J; Yang J; Neelapu S; Kwak LW; Hou J; Yi Q
Blood; 2012 Jan; 119(1):161-9. PubMed ID: 22049519
[TBL] [Abstract][Full Text] [Related]
18. HLA-A2 and -A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice.
Motomura Y; Ikuta Y; Kuronuma T; Komori H; Ito M; Tsuchihara M; Tsunoda Y; Shirakawa H; Baba H; Nishimura Y; Kinoshita T; Nakatsura T
Int J Oncol; 2008 May; 32(5):985-90. PubMed ID: 18425324
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors.
Bae J; Hideshima T; Tai YT; Song Y; Richardson P; Raje N; Munshi NC; Anderson KC
Leukemia; 2018 Sep; 32(9):1932-1947. PubMed ID: 29487385
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
Imai K; Hirata S; Irie A; Senju S; Ikuta Y; Yokomine K; Harao M; Inoue M; Tsunoda T; Nakatsuru S; Nakagawa H; Nakamura Y; Baba H; Nishimura Y
Clin Cancer Res; 2008 Oct; 14(20):6487-95. PubMed ID: 18927288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
